Literature DB >> 10769670

Telomerase assay as a possible predictor of the response to anticancer chemotherapy.

M Terashima1, I Takiyama, N Uesugi, N Sasaki, A Takagane, Y Hayakawa, K Abe, M Araya, S Nishizuka, O Shimooki, T Nakaya, T Irinoda, H Yonezawa, K Oyama, K Saito.   

Abstract

BACKGROUND: The correlation between telomerase activity and antitumor effects was investigated in cell lines of human gastric (MKN-28, MKN-45, and MKN-74) and breast (T-47D, MCF-7, ZR75-1) cancers to evaluate the possibility of utilizing this enzyme to predict tumor response to chemotherapy.
MATERIALS AND METHODS: After culture with various concentrations of 5-fluorouracil (5-FU) or doxorubicin (DOX) for 3 days, cell viability (trypan blue exclusion), cell cycle distribution (flow cytometry), and telomerase (TRAP-EZE) were measured.
RESULTS: Telomerase activity correlated significantly with the number of viable cells. After drug exposure, this activity decreased rapidly in a dose-dependent fashion in most cell lines. There was no correlation between telomerase activity and the distribution of cells in the cell cycle.
CONCLUSIONS: As the assay for telomerase activity is extremely sensitive and is virtually specific to cancer cells, this method may prove useful for the sensitivity testing of small specimens of human tumors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10769670

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  1 in total

1.  Long-term cultivation of colorectal carcinoma cells with anti-cancer drugs induces drug resistance and telomere elongation: an in vitro study.

Authors:  N Kuranaga; N Shinomiya; H Mochizuki
Journal:  BMC Cancer       Date:  2001-08-01       Impact factor: 4.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.